Literature DB >> 17498737

HIF-1alpha induced-VEGF overexpression in bone marrow stem cells protects cardiomyocytes against ischemia.

Ying Dai1, Meifeng Xu, Yigang Wang, Zeeshan Pasha, Tingyu Li, Muhammad Ashraf.   

Abstract

Hypoxia inducible factor-1alpha (HIF-1alpha) is a proangiogenic transcription factor stabilized and activated under hypoxia. It regulates the expression of numerous target genes, including vascular endothelial growth factor (VEGF) and other cytoprotective proteins. In this study, we hypothesized that bone marrow stem cells (BMSCs) secrete growth factors which protect cardiomyocytes via HIF-1alpha pathway. BMSCs were obtained from transgenic mice overexpressing green fluorescent protein (GFP). The study was carried out in vitro using co-culture of BMSCs with cardiomyocytes. LDH release, MTT uptake, DNA fragmentation and annexin-V positive cells were used as cell injury markers. The level of HIF-1alpha protein as well as its activated form and VEGF were measured by ELISA. The expression of HIF-1alpha and VEGF in BMSCs was analyzed by quantitative PCR and cellular localization was determined by immunohistochemistry. LDH release was increased and MTT uptake was decreased after exposure of cardiomyocytes to hypoxia for 30 h, which were prevented by co-culturing cardiomyocytes with BMSCs. Cardiomyocyte apoptosis induced by hypoxia and H(2)O(2) was also reduced by co-culture with BMSCs. VEGF release from BMSCs was significantly increased in parallel with high level of HIF-1alpha in BMSCs following anoxia or hypoxia in a time-dependent manner. Although no significant up-regulation could be seen in HIF-1alpha mRNA, HIF-1alpha protein and its activated form were markedly increased and translocated to the nucleus or peri-nuclear area. The increase and translocation of HIF-1alpha in BMSCs were completely blocked by 2-methoxyestradiol (2-ME2; 5 mumol), a HIF-1alpha inhibitor. Moreover, the protection of cardiomyocytes by BMSC and VEGF secretion was abolished by neutralizing HIF-1alpha antibody in a concentration dependent manner (200-3200 ng/ml). Bone marrow stem cells protect cardiomyocytes by up-regulation of VEGF via activating HIF-1alpha.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17498737      PMCID: PMC1995444          DOI: 10.1016/j.yjmcc.2007.04.001

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  42 in total

Review 1.  Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression.

Authors:  Roland H Wenger
Journal:  FASEB J       Date:  2002-08       Impact factor: 5.191

2.  Calcium preconditioning inhibits mitochondrial permeability transition and apoptosis.

Authors:  M Xu; Y Wang; K Hirai; A Ayub; M Ashraf
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-02       Impact factor: 4.733

3.  Activation of transcription factors by drugs inducing oxidative stress in rat liver.

Authors:  Lorenza Tacchini; Daniela Fusar-Poli; Aldo Bernelli-Zazzera
Journal:  Biochem Pharmacol       Date:  2002-01-15       Impact factor: 5.858

Review 4.  Hypoxia: the tumor's gateway to progression along the angiogenic pathway.

Authors:  C Brahimi-Horn; E Berra; J Pouysségur
Journal:  Trends Cell Biol       Date:  2001-11       Impact factor: 20.808

5.  In vitro and in vivo effects of bone marrow stem cells on cardiac structure and function.

Authors:  Meifeng Xu; Ryota Uemura; Ying Dai; Yigang Wang; Zeeshan Pasha; Muhammad Ashraf
Journal:  J Mol Cell Cardiol       Date:  2006-12-20       Impact factor: 5.000

6.  Hepatocyte growth factor protects cardiac myocytes against oxidative stress-induced apoptosis.

Authors:  K Kitta; R M Day; T Ikeda; Y J Suzuki
Journal:  Free Radic Biol Med       Date:  2001-10-01       Impact factor: 7.376

7.  Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes.

Authors:  Cornel Badorff; Ralf P Brandes; Rüdiger Popp; Stefan Rupp; Carmen Urbich; Alexandra Aicher; Ingrid Fleming; Rudi Busse; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Circulation       Date:  2003-02-25       Impact factor: 29.690

8.  Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia.

Authors:  Atsuhiko Kawamoto; Tengis Tkebuchava; Jun-Ichi Yamaguchi; Hiromi Nishimura; Young-Sup Yoon; Charles Milliken; Shigeki Uchida; Osamu Masuo; Hideki Iwaguro; Hong Ma; Allison Hanley; Marcy Silver; Marianne Kearney; Douglas W Losordo; Jeffrey M Isner; Takayuki Asahara
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

Review 9.  Signal transduction to hypoxia-inducible factor 1.

Authors:  Gregg Semenza
Journal:  Biochem Pharmacol       Date:  2002-09       Impact factor: 5.858

10.  G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4.

Authors:  Isabelle Petit; Martine Szyper-Kravitz; Arnon Nagler; Meir Lahav; Amnon Peled; Liliana Habler; Tanya Ponomaryov; Russell S Taichman; Fernando Arenzana-Seisdedos; Nobutaka Fujii; Judith Sandbank; Dov Zipori; Tsvee Lapidot
Journal:  Nat Immunol       Date:  2002-06-17       Impact factor: 25.606

View more
  68 in total

1.  Effects of hypoxic preconditioning on expression of transcription factor NGFI-A in the rat brain after unavoidable stress in the "learned helplessness" model.

Authors:  K A Baranova; E A Rybnikova; V I Mironova; M O Samoilov
Journal:  Neurosci Behav Physiol       Date:  2010-06-11

Review 2.  Molecular mechanisms of action and therapeutic uses of pharmacological inhibitors of HIF-prolyl 4-hydroxylases for treatment of ischemic diseases.

Authors:  Vaithinathan Selvaraju; Narasimham L Parinandi; Ram Sudheer Adluri; Joshua W Goldman; Naveed Hussain; Juan A Sanchez; Nilanjana Maulik
Journal:  Antioxid Redox Signal       Date:  2013-10-31       Impact factor: 8.401

3.  Vascular endothelial growth factor-A signaling in bone marrow-derived endothelial progenitor cells exposed to hypoxic stress.

Authors:  Brian R Hoffmann; Jordan R Wagner; Anthony R Prisco; Agnieszka Janiak; Andrew S Greene
Journal:  Physiol Genomics       Date:  2013-09-10       Impact factor: 3.107

4.  Mechanical loading of stem cells for improvement of transplantation outcome in a model of acute myocardial infarction: the role of loading history.

Authors:  Theresa R Cassino; Lauren Drowley; Masaho Okada; Sarah A Beckman; Bradley Keller; Kimimasa Tobita; Philip R Leduc; Johnny Huard
Journal:  Tissue Eng Part A       Date:  2012-03-07       Impact factor: 3.845

5.  HSPA12B and repairing the heart: beauty in simplicity.

Authors:  Fouad A Zouein; Mazen Kurdi; George W Booz
Journal:  Cardiovasc Res       Date:  2013-07-18       Impact factor: 10.787

6.  Synergistically combined gene delivery for enhanced VEGF secretion and antiapoptosis.

Authors:  Young-Wook Won; Minhyung Lee; Hyun Ah Kim; Kihoon Nam; David A Bull; Sung Wan Kim
Journal:  Mol Pharm       Date:  2013-09-23       Impact factor: 4.939

7.  Genetic engineering and stem cells: combinatorial approaches for cardiac cell therapy.

Authors:  Robert D Kirkton; Nenad Bursac
Journal:  IEEE Eng Med Biol Mag       Date:  2008 May-Jun

Review 8.  Obesity, Hypertension, and Cardiac Dysfunction: Novel Roles of Immunometabolism in Macrophage Activation and Inflammation.

Authors:  Alan J Mouton; Xuan Li; Michael E Hall; John E Hall
Journal:  Circ Res       Date:  2020-03-12       Impact factor: 17.367

9.  Characteristics of Mesenchymal Stem Cells - New Stars in Regenerative Medicine or Unrecognized Old Fellows in Autologous Regeneration?

Authors:  Richard Schäfer; Hinnak Northoff
Journal:  Transfus Med Hemother       Date:  2008-05-21       Impact factor: 3.747

10.  Enhancement of myocardial regeneration through genetic engineering of cardiac progenitor cells expressing Pim-1 kinase.

Authors:  Kimberlee M Fischer; Christopher T Cottage; Weitao Wu; Shabana Din; Natalie A Gude; Daniele Avitabile; Pearl Quijada; Brett L Collins; Jenna Fransioli; Mark A Sussman
Journal:  Circulation       Date:  2009-11-09       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.